The effect of L-alanine therapy in a patient with adult onset glycogen storage disease type II
- 127 Downloads
Adult-onset glycogen storage disease type II (GSD II) (McKusick 232300) is a progressive disabling myopathy. At present there is no treatment of proven clinical efficacy. Enzyme replacement therapy may in the future provide benefit but it will be costly and is not yet freely available. L-Alanine, a simple and relatively cheap therapy, has been shown to reduce protein degradation in GSD II patients but has not previously been assessed for clinical benefit in a controlled study. In this study L-alanine was assessed in a double blind, placebo-controlled, crossover n = 1 study. Assessments consisted of spirometry, cardiopulmonary exercise testing, quality of life measurements, biochemical markers and assessment by the criterion 4-component model of body composition. Alanine therapy was associated with a 15% gain in total body protein. However, the patient showed no functional improvement and reported feeling worse after treatment. Further controlled studies in a small group may be warranted, but not widespread use of this therapy.
KeywordsAlanine Body Composition Clinical Efficacy Myopathy Exercise Testing
Unable to display preview. Download preview PDF.
- Fuller NJ, Jebb SA, Coward WA, Elia M (1992) Four-component model for the assessment of body composition in humans: comparison with alternative methods, and evaluation of the density and hydration of fat-free mass. Clin Sci (Lond) 82(6): 687–693.Google Scholar
- Haroun D, Wells JC, Williams JE, Fuller NJ, Fewtrell MS, Lawson MS (2005) Composition of the fat-free mass in obese and nonobese children: matched case-control analyses. Int J Obes (Lond) 29(1): 29–36.Google Scholar
- Hobart JC, Lamping DL, Fitzpatrick R, et al (2000) Measuring the walking ability of people with multiple sclerosis (MS): a novel, patient based, and rigorous 12-item measure. Qual Life Res 9: 286.Google Scholar
- Jenkinson C, Coulter A, Wright L (1993) Short Form 36 (SF-36) Health survey questionnaire: normative data for adults of working age. BMJ 306: 1437–1440.Google Scholar